Rituximab, Cyclophosphamide, and Corticosteroids ( DrugBank: Rituximab, Cyclophosphamide )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
222 | 一次性ネフローゼ症候群 | 1 |
222. 一次性ネフローゼ症候群
臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05679336 (ClinicalTrials.gov) | May 1, 2018 | 28/11/2022 | Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy | Rituximab, Cyclophosphamide, and Corticosteroids at Low Cumulative Doses to Induce Remission in Primary Membranous Nephropathy | Membranous Nephropathy - PLA2R Induced | Drug: Rituximab, Cyclophosphamide, and Corticosteroids | St. Petersburg State Pavlov Medical University | NULL | Recruiting | 18 Years | 75 Years | All | 40 | N/A | Russian Federation |